Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;31(11):2740.
doi: 10.1681/ASN.2020071061. Epub 2020 Sep 11.

The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD Injury

Mark Peter Rutkowski  1
Affiliations
Comment

The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD Injury

Mark Peter Rutkowski. J Am Soc Nephrol. 2020 Nov.
No abstract available

Keywords: FDA drug label; chronic kidney disease; clinical epidemiology; creatinine; disparities; estimated glomerular filtration rate; metformin.

PubMed Disclaimer

Comment in

  • Authors' Reply.
    Shin JI, Sang Y, Dunning SC, Grams ME. Shin JI, et al. J Am Soc Nephrol. 2020 Nov;31(11):2740-2741. doi: 10.1681/ASN.2020081171. Epub 2020 Sep 11. J Am Soc Nephrol. 2020. PMID: 32931448 Free PMC article. No abstract available.

Comment on

References

    1. Shin JI, Sang Y, Chang AR, Dunning SC, Coresh J, Inker LA, et al. .: The FDA metformin label change and racial and sex disparities in metformin prescription among patients with CKD. J Am Soc Nephrol 31: 1847–1858, 2020. - PMC - PubMed
    1. Eneanya ND, Yang W, Reese PP: Reconsidering the consequences of using race to estimate kidney function. JAMA 322: 113–114, 2019. - PubMed
    1. Levey AS, Titan SM, Powe NR, Coresh J, Inker LA: Kidney disease, race, and GFR estimation. Clin J Am Soc Nephrol 15: 1203–1212, 2020. - PMC - PubMed

MeSH terms